UAE exit shakes OPEC – But will it really change oil prices?
Amrita Sen, founder and director of market intelligence at Energy Aspects discusses UAE’s decision to leave OPEC and how the justification seems intriguing given the oil supply constrain all OPEC members are facing as well. She also discusses how this …
CNBC’s UK Exchange newsletter: Can ‘Savvy the Squirrel’ drive Britons nuts for savings?
The big guns of the U.K. savings industry have launched a campaign to persuade households to “squirrel” money away. The big question is whether it will succeed.
European stocks to open lower as UAE OPEC exit complicates oil supply outlook
European stocks are expected to open broadly lower on Wednesday as investors react to the latest upset for OPEC and renewed concerns over the AI sector.
UBS profits rocket 80% to $3 billion for first quarter beat, shares pop 5%
UBS reported its first quarter earnings on Wednesday, with net profits beating analyst estimates.
Major data center company pauses investment decisions in Middle East amid Iran war, CEO tells CNBC
Regional uncertainty hangs over the previously booming AI infrastructure and data center sector in the region.
UAE’s departure from the OPEC oil cartel is not without precedent. Who could be next?
The United Arab Emirates’ decision to leave OPEC is reverberating across global energy markets, sparking questions on who else could follow.
U.S. warns banks of sanctions risk over China ‘teapot’ refineries handling Iranian oil
The alert said China purchases approximately 90% of Iran’s oil exports, with teapot refineries accounting for the majority of these imports.
Australia reports lower-than-expected first-quarter inflation — but price growth hits 2-year high
The first-quarter inflation figure was lower than the 4.2% expected by economists polled by Reuters.
CNBC Daily Open: Oil takes another hit, but chips steal the spotlight
Just as oil prices are looking stable (albeit higher) due to a ceasefire, the market took another blow as the United Arab Emirates exited the OPEC.
Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
Purdue Pharma was sentenced Tuesday to $5.5 billion in fines and penalties on charges of deceiving regulators and paying doctors to boost opioid sales.
